Alzheimer’s Approval, COVID-19 Vaccines Put Spotlight On Biotech Sector, But What’s Next?
For most of the past year, just a handful of companies carried the biotech sector, thanks to their quick responses to the COVID-19 pandemic.
PreMarket Prep Stock Of The Day: Pfizer
Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind those moves and the corresponding price action for the upcoming session.
Former NYSE Trader David Green “I Want To Buy $AMC’, Thinks It’s Going To Rise
Veteran trader David Green pointed out the strength of AMC Entertainment Holdings Inc (NYSE: AMC) Tuesday morning. The stock opened slightly up, around $35 a share, and continued to climb throughout the trading day, rising more than 20% to around $42 a share.
EMA Starts Rolling Review Of Glaxo – Sanofi COVID-19 Vaccine
EMA's human medicines committee has kicked off a rolling review of a COVID-19 vaccine from Sanofi SA (NASDAQ:
Unusual Options Activity Insight: Novavax
On Tuesday, shares of Novavax (NASDAQ:NVAX) saw unusual options activity. After the option alert, the stock price moved down to $201.48.
Is Novavax Breaking Out After The Rally?
Novavax, Inc. (NASDAQ: NVAX) shares rallied higher Monday after renewed COVID-19 concerns.
Why Novavax’s Stock Is Trading Higher Today
Novavax Inc (NASDAQ: NVAX) is trading significantly higher Monday amid renewed COVID-19 concerns.
Unusual Options Activity Insight: Novavax
Novavax (NASDAQ:NVAX) shares experienced unusual options activity on Thursday. The stock price moved up to $180.27 following the option alert.
61 Biggest Movers From Yesterday
Gainers
Newegg Commerce, Inc. (NASDAQ: NEGG) shares surged 148.4% to close at $67.57 on Wednesday after jumping around 42% on Tuesday.